• In Memoriam
  • What is my risk?
  • Disease Stages
    • WISH I HAD KNOWN
    • NASH EDUCATIONAL VIDEOS
    • AT RISK?
      • Overweight?
      • Failed to Lose Weight?
      • NASH Overview
    • FATTY LIVER
      • Overview NAFLD
      • 1 in 3 Have It
      • Diet
    • NAFLD
      • Overview
      • Symptoms
      • Should I Be Scared?
      • Diet
    • NASH
      • Overview
      • Symptoms
      • Diet
      • NASH Education Program
    • CIRRHOSIS
      • Overview
      • End Stage Liver Disease
      • Multiple Listing
      • Living Donors
      • Become a Donor
  • Food
    • Diet Information
      • Liver Friendly Diet
      • SIMPLEST DIET ADVICE
      • COMPARE Diets
      • NAFLD Diet
      • NASH Diet
      • HEALTHY Diet
    • Food articles
      • QUICK EATING VIDEOS
      • Olive Oil
      • Sugar
      • Coffee
      • Salt
      • Omega 3
      • Triglycerides
      • Liver Cleanses - Helpful?
      • Supplements useful?
      • Supplements NOT
      • Apollo Olive Oil
  • Voices our blogs
    • Foundation blog
    • Patient Stories
    • Caregiver Stories
    • Meagan's Place
    • Sarah Larsen
  • Wellness Ambassador
    • wellness league search
    • Ambassador Donation Portal
  • noninvasive tests
    • noninvasive basic
    • LIVERFASt
    • NIS4
    • FIB-4 Index
    • APRI
    • ELF
    • FibroScan
    • Velacur
  • SCIENCE
    • Basic Liver Facts
    • Disease Facts
    • NASH in videos
    • Science Behind Diet
    • Right Upper Quadrant (RUQ) Pain
  • Projects
    • SCREENING PROJECT
      • Big Picture
      • Pilot Project
      • Project Overview
      • National Fatty Liver Registry
      • Medical Facts
      • SUNN Study
    • Webinars
      • LIVER Webinar Series
      • Wellness Webinars
    • The State of Steatotic (Fatty) Liver Care in America Survey
      • 2022 Findings
      • 2023 Findings
      • 2024 Findings
  • RESOURCES
    • How To Help
      • DONATE
      • NETWORK FOR GOOD
      • PayPal
      • Donate Your Change
    • Clincal Trial Overview
    • Healthwell Financial Assistance
    • Newsletter Sign-Up
    • Blow A Kiss
    • CBD
    • HIGADOGRASO
  • Press
    • FLF Launches a Public-Private Partnership to Combat the Silent Epidemic of NAFLD
    • FLF and Fibronostics form a patient education partnership
    • Gabriella Wan joins FLF
    • FLF Appoints New Chief Financial Officer
    • Echosens Aligns with FLF to Accelerate Screening for Undiagnosed NAFLD and NASH
    • SUNN-1 Recruitment Complete
    • At Mexican Consulate
    • EASL 2019
    • Press FAQ --- Fatty Liver Foundation
    • Dancing with the Dark Angel
    • Kiss and Click Challenge
    • Dr Charlton, lifesaver
    • Searching for a cure
    • GE Reports MRI Elastography
    • Living with cirrhosis
    • Silent killer stalks 100 million
    • Skydiving Granny fights depression
    • Fatty Liver Foundation Launches the State of NAFLD/NASH Care in America ™ Initiative to Support Improved Patient Care Experience
    • FATTY LIVER FOUNDATION TO MARK INTERNATIONAL NASH DAY WITH THREE INTERACTIVE PROGRAMS OFFERING INFORMATION, INSPIRATION, AND SUPPORT FOR PEOPLE AT-RISK OF OR LIVING WITH NAFLD/NASH
    • FATTY LIVER FOUNDATION’S ANNUAL NATIONAL SURVEY AIMS TO RESHAPE NAFLD/NASH CARE IN THE U.S.
    • FATTY LIVER FOUNDATION EXPRESSES CONCERNS ABOUT ICER’S EVIDENCE REPORT ON NASH TREATMENTS
    • Pivotal FDA Advisory Committee Meeting: Fatty Liver Foundation Advocates for Approval of Groundbreaking NASH Treatment
    • Fatty Liver Foundation Partners With Secure AI Labs To Empower NAFLD and NASH Community With New Patient-Facing Tool
    • Shining a Spotlight and Taking Action for Liver Health: Fatty Liver Foundation Marks International NASH Day
    • Fatty Liver Foundation Celebra el Día Internacional de la EHNA (Esteatohepatitis No Alcohólica)
    • Fatty Liver Foundation and Society for Sober Liver Survival Forge Groundbreaking Collaboration in the Fight Against Liver Diseases
  • Sponsors
    • Sponsorship
    • In Kind Donations
    • fibronostics
    • Geneva Eskridge
    • Intercept Pharmaceuticals
    • Echosens
    • madrigal
    • Galectin
    • Bristol Myers Squibb
    • Gilead Sciences
    • 89 Bio
    • Akero
    • Abbvie
    • Merck
    • Novo Nordisk
    • Boehringer Ingelheim
    • Perspectum
    • Pfizer
    • Regeneron
    • Altimmune
    • M3
  • ABOUT
    • About FLF
      • My Story
      • How to Help
      • Management
      • Non-Profit 501(c)
      • Idaho Registration
      • Mission
      • Disclaimer
      • Privacy Policy
      • Contact Us
      • Medical Advisory Board
    • Community Action
    • EASL 2019 press kit
    • Learn About FLF
    • Jobs & Internships
  • drug_pipeline
  • WISH I HAD KNOWN
  • NASH EDUCATIONAL VIDEOS
  • AT RISK?
    • Overweight?
    • Failed to Lose Weight?
    • NASH Overview
  • FATTY LIVER
    • Overview NAFLD
    • 1 in 3 Have It
    • Diet
  • NAFLD
    • Overview
    • Symptoms
    • Should I Be Scared?
    • Diet
  • NASH
    • Overview
    • Symptoms
    • Diet
    • NASH Education Program
  • CIRRHOSIS
    • Overview
    • End Stage Liver Disease
    • Multiple Listing
    • Living Donors
    • Become a Donor
  • Diet Information
    • Liver Friendly Diet
    • SIMPLEST DIET ADVICE
    • COMPARE Diets
    • NAFLD Diet
    • NASH Diet
    • HEALTHY Diet
  • Food articles
    • QUICK EATING VIDEOS
    • Olive Oil
    • Sugar
    • Coffee
    • Salt
    • Omega 3
    • Triglycerides
    • Liver Cleanses - Helpful?
    • Supplements useful?
    • Supplements NOT
    • Apollo Olive Oil
  • Foundation blog
  • Patient Stories
  • Caregiver Stories
  • Meagan's Place
  • Sarah Larsen
  • wellness league search
  • Ambassador Donation Portal
  • noninvasive basic
  • LIVERFASt
  • NIS4
  • FIB-4 Index
  • APRI
  • ELF
  • FibroScan
  • Velacur
  • Basic Liver Facts
  • Disease Facts
  • NASH in videos
  • Science Behind Diet
  • Right Upper Quadrant (RUQ) Pain
  • SCREENING PROJECT
    • Big Picture
    • Pilot Project
    • Project Overview
    • National Fatty Liver Registry
    • Medical Facts
    • SUNN Study
  • Webinars
    • LIVER Webinar Series
    • Wellness Webinars
  • The State of Steatotic (Fatty) Liver Care in America Survey
    • 2022 Findings
    • 2023 Findings
    • 2024 Findings
  • How To Help
    • DONATE
    • NETWORK FOR GOOD
    • PayPal
    • Donate Your Change
  • Clincal Trial Overview
  • Healthwell Financial Assistance
  • Newsletter Sign-Up
  • Blow A Kiss
  • CBD
  • HIGADOGRASO
  • FLF Launches a Public-Private Partnership to Combat the Silent Epidemic of NAFLD
  • FLF and Fibronostics form a patient education partnership
  • Gabriella Wan joins FLF
  • FLF Appoints New Chief Financial Officer
  • Echosens Aligns with FLF to Accelerate Screening for Undiagnosed NAFLD and NASH
  • SUNN-1 Recruitment Complete
  • At Mexican Consulate
  • EASL 2019
  • Press FAQ --- Fatty Liver Foundation
  • Dancing with the Dark Angel
  • Kiss and Click Challenge
  • Dr Charlton, lifesaver
  • Searching for a cure
  • GE Reports MRI Elastography
  • Living with cirrhosis
  • Silent killer stalks 100 million
  • Skydiving Granny fights depression
  • Fatty Liver Foundation Launches the State of NAFLD/NASH Care in America ™ Initiative to Support Improved Patient Care Experience
  • FATTY LIVER FOUNDATION TO MARK INTERNATIONAL NASH DAY WITH THREE INTERACTIVE PROGRAMS OFFERING INFORMATION, INSPIRATION, AND SUPPORT FOR PEOPLE AT-RISK OF OR LIVING WITH NAFLD/NASH
  • FATTY LIVER FOUNDATION’S ANNUAL NATIONAL SURVEY AIMS TO RESHAPE NAFLD/NASH CARE IN THE U.S.
  • FATTY LIVER FOUNDATION EXPRESSES CONCERNS ABOUT ICER’S EVIDENCE REPORT ON NASH TREATMENTS
  • Pivotal FDA Advisory Committee Meeting: Fatty Liver Foundation Advocates for Approval of Groundbreaking NASH Treatment
  • Fatty Liver Foundation Partners With Secure AI Labs To Empower NAFLD and NASH Community With New Patient-Facing Tool
  • Shining a Spotlight and Taking Action for Liver Health: Fatty Liver Foundation Marks International NASH Day
  • Fatty Liver Foundation Celebra el Día Internacional de la EHNA (Esteatohepatitis No Alcohólica)
  • Fatty Liver Foundation and Society for Sober Liver Survival Forge Groundbreaking Collaboration in the Fight Against Liver Diseases
  • Sponsorship
  • In Kind Donations
  • fibronostics
  • Geneva Eskridge
  • Intercept Pharmaceuticals
  • Echosens
  • madrigal
  • Galectin
  • Bristol Myers Squibb
  • Gilead Sciences
  • 89 Bio
  • Akero
  • Abbvie
  • Merck
  • Novo Nordisk
  • Boehringer Ingelheim
  • Perspectum
  • Pfizer
  • Regeneron
  • Altimmune
  • M3
  • About FLF
    • My Story
    • How to Help
    • Management
    • Non-Profit 501(c)
    • Idaho Registration
    • Mission
    • Disclaimer
    • Privacy Policy
    • Contact Us
    • Medical Advisory Board
  • Community Action
  • EASL 2019 press kit
  • Learn About FLF
  • Jobs & Internships




    • donate now The Fatty Liver Foundation
    • In Memoriam
    • What is my risk?
    • Disease Stages
      • WISH I HAD KNOWN
      • NASH EDUCATIONAL VIDEOS
      • AT RISK?
        • Overweight?
        • Failed to Lose Weight?
        • NASH Overview
      • FATTY LIVER
        • Overview NAFLD
        • 1 in 3 Have It
        • Diet
      • NAFLD
        • Overview
        • Symptoms
        • Should I Be Scared?
        • Diet
      • NASH
        • Overview
        • Symptoms
        • Diet
        • NASH Education Program
      • CIRRHOSIS
        • Overview
        • End Stage Liver Disease
        • Multiple Listing
        • Living Donors
        • Become a Donor
    • Food
      • Diet Information
        • Liver Friendly Diet
        • SIMPLEST DIET ADVICE
        • COMPARE Diets
        • NAFLD Diet
        • NASH Diet
        • HEALTHY Diet
      • Food articles
        • QUICK EATING VIDEOS
        • Olive Oil
        • Sugar
        • Coffee
        • Salt
        • Omega 3
        • Triglycerides
        • Liver Cleanses - Helpful?
        • Supplements useful?
        • Supplements NOT
        • Apollo Olive Oil
    • Voices our blogs
      • Foundation blog
      • Patient Stories
      • Caregiver Stories
      • Meagan's Place
      • Sarah Larsen
    • Wellness Ambassador
      • wellness league search
      • Ambassador Donation Portal
    • noninvasive tests
      • noninvasive basic
      • LIVERFASt
      • NIS4
      • FIB-4 Index
      • APRI
      • ELF
      • FibroScan
      • Velacur
    • SCIENCE
      • Basic Liver Facts
      • Disease Facts
      • NASH in videos
      • Science Behind Diet
      • Right Upper Quadrant (RUQ) Pain
    • Projects
      • SCREENING PROJECT
        • Big Picture
        • Pilot Project
        • Project Overview
        • National Fatty Liver Registry
        • Medical Facts
        • SUNN Study
      • Webinars
        • LIVER Webinar Series
        • Wellness Webinars
      • The State of Steatotic (Fatty) Liver Care in America Survey
        • 2022 Findings
        • 2023 Findings
        • 2024 Findings
    • RESOURCES
      • How To Help
        • DONATE
        • NETWORK FOR GOOD
        • PayPal
        • Donate Your Change
      • Clincal Trial Overview
      • Healthwell Financial Assistance
      • Newsletter Sign-Up
      • Blow A Kiss
      • CBD
      • HIGADOGRASO
    • Press
      • FLF Launches a Public-Private Partnership to Combat the Silent Epidemic of NAFLD
      • FLF and Fibronostics form a patient education partnership
      • Gabriella Wan joins FLF
      • FLF Appoints New Chief Financial Officer
      • Echosens Aligns with FLF to Accelerate Screening for Undiagnosed NAFLD and NASH
      • SUNN-1 Recruitment Complete
      • At Mexican Consulate
      • EASL 2019
      • Press FAQ --- Fatty Liver Foundation
      • Dancing with the Dark Angel
      • Kiss and Click Challenge
      • Dr Charlton, lifesaver
      • Searching for a cure
      • GE Reports MRI Elastography
      • Living with cirrhosis
      • Silent killer stalks 100 million
      • Skydiving Granny fights depression
      • Fatty Liver Foundation Launches the State of NAFLD/NASH Care in America ™ Initiative to Support Improved Patient Care Experience
      • FATTY LIVER FOUNDATION TO MARK INTERNATIONAL NASH DAY WITH THREE INTERACTIVE PROGRAMS OFFERING INFORMATION, INSPIRATION, AND SUPPORT FOR PEOPLE AT-RISK OF OR LIVING WITH NAFLD/NASH
      • FATTY LIVER FOUNDATION’S ANNUAL NATIONAL SURVEY AIMS TO RESHAPE NAFLD/NASH CARE IN THE U.S.
      • FATTY LIVER FOUNDATION EXPRESSES CONCERNS ABOUT ICER’S EVIDENCE REPORT ON NASH TREATMENTS
      • Pivotal FDA Advisory Committee Meeting: Fatty Liver Foundation Advocates for Approval of Groundbreaking NASH Treatment
      • Fatty Liver Foundation Partners With Secure AI Labs To Empower NAFLD and NASH Community With New Patient-Facing Tool
      • Shining a Spotlight and Taking Action for Liver Health: Fatty Liver Foundation Marks International NASH Day
      • Fatty Liver Foundation Celebra el Día Internacional de la EHNA (Esteatohepatitis No Alcohólica)
      • Fatty Liver Foundation and Society for Sober Liver Survival Forge Groundbreaking Collaboration in the Fight Against Liver Diseases
    • Sponsors
      • Sponsorship
      • In Kind Donations
      • fibronostics
      • Geneva Eskridge
      • Intercept Pharmaceuticals
      • Echosens
      • madrigal
      • Galectin
      • Bristol Myers Squibb
      • Gilead Sciences
      • 89 Bio
      • Akero
      • Abbvie
      • Merck
      • Novo Nordisk
      • Boehringer Ingelheim
      • Perspectum
      • Pfizer
      • Regeneron
      • Altimmune
      • M3
    • ABOUT
      • About FLF
        • My Story
        • How to Help
        • Management
        • Non-Profit 501(c)
        • Idaho Registration
        • Mission
        • Disclaimer
        • Privacy Policy
        • Contact Us
        • Medical Advisory Board
      • Community Action
      • EASL 2019 press kit
      • Learn About FLF
      • Jobs & Internships
    • drug_pipeline
  • WISH I HAD KNOWN
  • NASH EDUCATIONAL VIDEOS
  • AT RISK?
    • Overweight?
    • Failed to Lose Weight?
    • NASH Overview
  • FATTY LIVER
    • Overview NAFLD
    • 1 in 3 Have It
    • Diet
  • NAFLD
    • Overview
    • Symptoms
    • Should I Be Scared?
    • Diet
  • NASH
    • Overview
    • Symptoms
    • Diet
    • NASH Education Program
  • CIRRHOSIS
    • Overview
    • End Stage Liver Disease
    • Multiple Listing
    • Living Donors
    • Become a Donor
  • Diet Information
    • Liver Friendly Diet
    • SIMPLEST DIET ADVICE
    • COMPARE Diets
    • NAFLD Diet
    • NASH Diet
    • HEALTHY Diet
  • Food articles
    • QUICK EATING VIDEOS
    • Olive Oil
    • Sugar
    • Coffee
    • Salt
    • Omega 3
    • Triglycerides
    • Liver Cleanses - Helpful?
    • Supplements useful?
    • Supplements NOT
    • Apollo Olive Oil
  • Foundation blog
  • Patient Stories
  • Caregiver Stories
  • Meagan's Place
  • Sarah Larsen
  • wellness league search
  • Ambassador Donation Portal
  • noninvasive basic
  • LIVERFASt
  • NIS4
  • FIB-4 Index
  • APRI
  • ELF
  • FibroScan
  • Velacur
  • Basic Liver Facts
  • Disease Facts
  • NASH in videos
  • Science Behind Diet
  • Right Upper Quadrant (RUQ) Pain
  • SCREENING PROJECT
    • Big Picture
    • Pilot Project
    • Project Overview
    • National Fatty Liver Registry
    • Medical Facts
    • SUNN Study
  • Webinars
    • LIVER Webinar Series
    • Wellness Webinars
  • The State of Steatotic (Fatty) Liver Care in America Survey
    • 2022 Findings
    • 2023 Findings
    • 2024 Findings
  • How To Help
    • DONATE
    • NETWORK FOR GOOD
    • PayPal
    • Donate Your Change
  • Clincal Trial Overview
  • Healthwell Financial Assistance
  • Newsletter Sign-Up
  • Blow A Kiss
  • CBD
  • HIGADOGRASO
  • FLF Launches a Public-Private Partnership to Combat the Silent Epidemic of NAFLD
  • FLF and Fibronostics form a patient education partnership
  • Gabriella Wan joins FLF
  • FLF Appoints New Chief Financial Officer
  • Echosens Aligns with FLF to Accelerate Screening for Undiagnosed NAFLD and NASH
  • SUNN-1 Recruitment Complete
  • At Mexican Consulate
  • EASL 2019
  • Press FAQ --- Fatty Liver Foundation
  • Dancing with the Dark Angel
  • Kiss and Click Challenge
  • Dr Charlton, lifesaver
  • Searching for a cure
  • GE Reports MRI Elastography
  • Living with cirrhosis
  • Silent killer stalks 100 million
  • Skydiving Granny fights depression
  • Fatty Liver Foundation Launches the State of NAFLD/NASH Care in America ™ Initiative to Support Improved Patient Care Experience
  • FATTY LIVER FOUNDATION TO MARK INTERNATIONAL NASH DAY WITH THREE INTERACTIVE PROGRAMS OFFERING INFORMATION, INSPIRATION, AND SUPPORT FOR PEOPLE AT-RISK OF OR LIVING WITH NAFLD/NASH
  • FATTY LIVER FOUNDATION’S ANNUAL NATIONAL SURVEY AIMS TO RESHAPE NAFLD/NASH CARE IN THE U.S.
  • FATTY LIVER FOUNDATION EXPRESSES CONCERNS ABOUT ICER’S EVIDENCE REPORT ON NASH TREATMENTS
  • Pivotal FDA Advisory Committee Meeting: Fatty Liver Foundation Advocates for Approval of Groundbreaking NASH Treatment
  • Fatty Liver Foundation Partners With Secure AI Labs To Empower NAFLD and NASH Community With New Patient-Facing Tool
  • Shining a Spotlight and Taking Action for Liver Health: Fatty Liver Foundation Marks International NASH Day
  • Fatty Liver Foundation Celebra el Día Internacional de la EHNA (Esteatohepatitis No Alcohólica)
  • Fatty Liver Foundation and Society for Sober Liver Survival Forge Groundbreaking Collaboration in the Fight Against Liver Diseases
  • Sponsorship
  • In Kind Donations
  • fibronostics
  • Geneva Eskridge
  • Intercept Pharmaceuticals
  • Echosens
  • madrigal
  • Galectin
  • Bristol Myers Squibb
  • Gilead Sciences
  • 89 Bio
  • Akero
  • Abbvie
  • Merck
  • Novo Nordisk
  • Boehringer Ingelheim
  • Perspectum
  • Pfizer
  • Regeneron
  • Altimmune
  • M3
  • About FLF
    • My Story
    • How to Help
    • Management
    • Non-Profit 501(c)
    • Idaho Registration
    • Mission
    • Disclaimer
    • Privacy Policy
    • Contact Us
    • Medical Advisory Board
  • Community Action
  • EASL 2019 press kit
  • Learn About FLF
  • Jobs & Internships

    • Learning


    Like us to spread the word
    Tweet

    Sign in with:

    Or sign up:


    Fatty Liver Foundation copyright 2025 all rights reserved

    The information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information should not be used as a substitute for professional diagnosis or treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. The Fatty Liver Foundation, its officers or contributors expressly disclaim responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site.

     

    connect

    Follow @LiverSaver on Twitter
    Sign in with Facebook, Twitter or email.
    Created with NationBuilder
    using a public theme by cStreet